|
|
Volumn 8, Issue 2, 2006, Pages 215-
|
|
Levosimendan therapy in decompensated chronic heart failure: Favourable haemodynamic and neurohormonal effects but for how long? [1]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BRAIN NATRIURETIC PEPTIDE;
C REACTIVE PROTEIN;
DRUG METABOLITE;
INTERLEUKIN 6;
LEVOSIMENDAN;
N [4 (1,4,5,6 TETRAHYDRO 4 METHYL 6 OXO 3 PYRIDAZINYL)PHENYL]ACETAMIDE;
OR 1855;
PROSTAGLANDIN E1;
UNCLASSIFIED DRUG;
DRUG BLOOD LEVEL;
DRUG EFFECT;
DRUG ELIMINATION;
DRUG HALF LIFE;
HEART FAILURE;
HEART HEMODYNAMICS;
HEART INDEX;
HEART LEFT VENTRICLE PERFORMANCE;
HUMAN;
LETTER;
LUNG ARTERY PRESSURE;
LUNG CAPILLARY PRESSURE;
MEDICAL ASSESSMENT;
PRIORITY JOURNAL;
C-REACTIVE PROTEIN;
CARDIOTONIC AGENTS;
HEART FAILURE;
HEMODYNAMICS;
HUMANS;
HYDRAZONES;
INTERLEUKIN-6;
NATRIURETIC PEPTIDE, BRAIN;
PYRIDAZINES;
TIME FACTORS;
TREATMENT OUTCOME;
|
|
EID: 32644453133
PISSN: 13889842
EISSN: None
Source Type: Journal
DOI: 10.1016/j.ejheart.2006.01.003 Document Type: Letter |
|
Times cited : (3)
|
|
References (4)
|
